SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA

Date
2017
Author
Tas, Faruk
Karabulut, Senem
Peker, Kivanc Derya
Yasasever, Ceren Tilgen
Karaman, Sule
Karabulut, Mehmet
Afsar, Cigdem Usul
Gemici, Eyup
Dagoglu, Nergiz
Metadata
Show full item record
Abstract
Background: Pancreatic adenocarcinoma (PA) is a very lethal malignancy. Different parameters have been found to be predictive and prognostic. This study was conducted to investigate the serum levels of interleukin-32 (IL-32) in patients with PA and the relationship with tumor progression and known prognostic parameters.
URI
http://hdl.handle.net/20.500.12627/160169
https://doi.org/10.19193/0393-6384_2017_4_091
Collections